PureIMS, Levodopa

PureIMS gears up for abbreviated registration of Levodopa Cyclops® DPI against OFF episodes in Parkinson's disease with the successful completion of a comparative pharmacokinetic study

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

PureIMS Netherlands United Kingdom United States of America

View original content:https://www.prnewswire.co.uk/news-releases/pureims-gears-up-for-abbreviated-registration-of-levodopa-cyclops-dpi-against-off-episodes-in-parkinsons-disease-with-the-successful-completion-of-a-comparative-pharmacokinetic-study-302038318.html

en | boerse | 67929547 |